MedTrace Logo

Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure

NCT02961478 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-03-19

No results posted yet for this study

Summary

IOXSOR study's purpose to determine the frequency of non resolutive renal failure (estimated by the clearance of iohexol) at end of stay in ICU patients who have had acute renal failure episode.

Conditions

  • Acute Renal Failure

Interventions

DRUG

IOHEXOL

Estimate iohexol clearance at the end of stay in intensive care for patients who had an episode of acute renal failure.

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • François BELONCLE, CCU-AH · University Hospital, Angers

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02961478 on ClinicalTrials.gov